Attached files
file | filename |
---|---|
8-K - CURRENT REPORT - cbdMD, Inc. | ycbd_8k.htm |
Exhibit 99.1
cbdMD, Inc. Announces Timing of Regular Monthly Dividend for
January 2020 for 8.0% Series A Cumulative Convertible Preferred
Stock
CHARLOTTE, NC, December 16, 2019 (BUSINESS NEWSWIRE) – cbdMD,
Inc. (NYSE American: YCBD), a nationally
recognized consumer cannabidiol (CBD) brand, today announced the
timing for the payment of its declared regular monthly dividend of
$0.0667 per share of its 8.0% Series A Cumulative Convertible
Preferred Stock (NYSE American: YCBD PR A) for January 2020. The
dividend will be payable on January 15, 2020 to holders of record
as of January 1, 2020. The dividend will be
paid in cash.
About cbdMD, Inc.
cbdMD,
Inc. (NYSE American: YCBD and NYSE American: YCBD PR A) owns and
operates the nationally recognized consumer cannabidiol (CBD) brand
cdbMD, whose current products include CBD gummies, CBD tinctures,
CBD topical, CBD bath bombs, CBD oils and CBD pet products. cbdMD,
Inc. is a nationally recognized consumer cannabidiol (CBD) brand
whose current products include CBD tinctures, CBD gummies, CBD
topicals, CBD bath bombs, and CBD pet products. cbdMD is also the
proud partner with the Big 3 Basketball League, Barstool Sports,
Bellator MMA, (a subsidiary of Viacom: NASDAQ:VIA), LifeTime and
Nitro Circus. To learn more about cbdMD, Inc. and our comprehensive
line of over 100 SKU’s of U.S. produced, THC-free CBD
products, please visit: www.cbdmd.com or
follow cbdMD on Instagram and
Facebook or
visit one of the 3,000 retail outlets that carry cbdMD
products.
Safe Harbor Statement
This release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. In some
cases, forward-looking statements can be identified by terminology
such as "may," "should," "potential," "continue," "expects,"
"anticipates," "intends," "plans," "believes," "estimates," and
similar expressions. These forward-looking statements are based on
management's expectations and assumptions as of the date of this
press release and are subject to a number of risks and
uncertainties, many of which are difficult to predict that could
cause actual results to differ materially from current expectations
and assumptions from those set forth or implied by any
forward-looking statements. The information in this release is
provided only as of the date of this release, and we undertake no
obligation to update any forward-looking statements contained in
this release on account of new information, future events, or
otherwise, except as required by law. The information which appears
on our website and our social media platforms is not part of this
press release.
Company Contact:
cbdMD, Inc.
Mark S. Elliott, Chief Financial Officer and Chief Operating
Officer
(704) 445-3060
mark.elliott@cbdMD.com